5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma

Dylan J. Kahl, Kim M. Hutchings, Erika Mathes Lisabeth, Andrew J. Haak, Jeffrey R. Leipprandt, Thomas Dexheimer, Dinesh Khanna, Pei Suen Tsou, Phillip L. Campbell, David A. Fox, Bo Wen, Duxin Sun, Marc Bailie, Richard R. Neubig, Scott D. Larsen

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of '5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds